Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common diabetes drug help adults born with heart defects?

NCT ID NCT06260059

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times

Summary

This study tests whether Empagliflozin (Jardiance), a drug already used for heart failure, can help adults with congenital heart disease whose heart function has recently declined. About 40 participants will take the drug and be monitored for changes in heart pumping strength, exercise ability, and inflammation. The goal is to see if this treatment can improve heart health and reduce hospitalizations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Children's Hospital of Pittsburgh

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

    Contact Email: •••••@•••••

  • Magee Women's Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Email: •••••@•••••

  • Presbyterian Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.